Comparison between YM099 and captopril in rats with renal mass reduction-induced progressive renal disease

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 2, 2005, Pages 367-369

  Yatsu, Takeyuki ^a   Aoki, Motonori ^a   Uchida, Wataru ^a   Inagaki, Osamu ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Antiproteinuric effect; KATP channel opener; Progressive renal disease; Proteinuria; Renal mass reduction; Renoprotection

Indexed keywords

2 (7,8 DIHYDRO 6,6 DIMETHYL 6H OXAZINO[2,3 E] 2,1,3 BENZOXADIAZOL 8 YL)PYRIDINE N OXIDE; BENZOXAZOLE DERIVATIVE; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG; YM 099; AMINE OXIDE; OXADIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; ENZYME INHIBITION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY MASS; MALE; NEPHRECTOMY; NONHUMAN; PROTEINURIA; RANDOMIZATION; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; COMPARATIVE STUDY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CAPTOPRIL; CYCLIC N-OXIDES; KIDNEY DISEASES; MALE; OXADIAZOLES; POTASSIUM CHANNELS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 14644439336     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.367     Document Type: Article

References (22)

1. Uchida W., Hirano Y., Taguchi T., Masuda N., Shirai Y., Satoh N., Takenaka T., Eur. J. Pharmacol., 264, 285-293 (1994).
2. Uchida W., Hirano Y., Shirai Y., Taguchi T., Masuda N., Shibasaki K., Hirano S., Matsumoto Y., Tsuzuki R., Yanagisawa I., Arch. Int. Pharmacodyn., 327, 330-343 (1994).
3. Hayashi K., Matsumura Y., Yoshida Y., Ohyama T., Hisaki K., Suzuki Y., Morimoto S., J. Pharmacol. Exp. Ther., 252, 1240-1246 (1990).
4. Tamaki T., Hasui K., Shoji T., Fukui K., Iwao H., Abe Y., J. Cardiovasc. Pharmacol., 17, 305-309 (1991).
5. Brenner B. M., Lawler E. V., Mackenzie H. S., Kidney Int., 49, 1774-1777 (1996).
6. Shimamura T., Morrison A. B., Am. J. Pathol., 79, 95-106 (1975).
7. Anderson S., Meyer T. W., Rennke H. G., Brenner B. M., J. Clin. Invest. 76, 612-619 (1985).
8. Noda M., Matsuo T., Fukuda R., Ohta M., Nagano H., Shibouta Y., Naka T., Nishikawa K., Imura Y., Kidney Int., 56, 898-909 (1999).
9. Badid C., Vincent M., McGregor B., Melin M., Hadj-Aissa A., Veysseyre C., Hartmann D. J., Desmouliere A., Laville M., Kidney Int., 58, 51-61 (2000).
10. Lewis E. J., Hunsicker L. G., Rohde R. D., N. Engl. J. Med., 329, 1456-1462 (1993).
11. Brooks D. P., Contino L. C., Short B. G., Gowan C., Trizna W., Edwards R. M., J. Pharmacol. Exp. Ther., 274, 1222-1227 (1995).
12. Brooks D. P., Short B. G., Cyronak M. J., Contino L. C., DiCristo M., Wang Y. X., Ruffolo R. R., Jr., Br. J. Pharmacol., 109, 581-586 (1993).
13. Remuzzi G., Bertani T., N. Engl. J. Med., 339, 1448-1456 (1998).
14. Yatsu T., Sanagi M., Fujimori A., Tomura Y., Hayashi K., Tanahashi M., Inagaki O., Pharmacol. Res., 47, 243-252 (2003).
15. Masuda N., Uchida W., Arai Y., Taguchi T., Tsuzuki R., Inagaki O., Jpn. J. Pharmacol., 61 (Suppl. 1), 209P (1993).
16. Davidsohn L., Henry J. B., "Clinical Diagnosis by Laboratory Methods," 14th ed., WB Saunders, Philadelphia, 1969.
17. Remuzzi G., Ruggenenti P., Benigni A., Kidney Int., 51, 2-15 (1997).
18. Mackenzie H. S., Brenner B. M., Am. J. Kidney Dis., 31, 161-170 (1998).
19. Gomez-Garre D., Largo R., Tejera N., Fortes J., Manzarbeitia F., Egido J., Hypertension, 37, 1171-1178 (2001).
20. Locatelli F., Vecchio L. D., Pozzoni P., Nephrol. Dial. Transplant., 17 (Suppl. 11), 2-7 (2002).
21. Hostetter T. H., Olson J. L., Rennke H. G., Venkalachalam M. A., Brenner B. M., Am. J. Physiol., 241, F85-F93 (1981).
22. Anonymous., Lancet, 349, 1857- 1863 (1997).